PD-1/PD-L1-IN 5
Modify Date: 2024-01-17 15:07:33
PD-1/PD-L1-IN 5 structure
|
Common Name | PD-1/PD-L1-IN 5 | ||
|---|---|---|---|---|
| CAS Number | 2170209-52-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H18N4O3S.xC2HF3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PD-1/PD-L1-IN 5PD-1/PD-L1-IN 5 is a PD-1/PD-L1 protein/protein interaction inhibitor extracted from patent WO2017222976A1, compound Example 1, has an IC50 of ≤100 nM[1]. |
| Name | PD-1/PD-L1-IN 5 |
|---|
| Description | PD-1/PD-L1-IN 5 is a PD-1/PD-L1 protein/protein interaction inhibitor extracted from patent WO2017222976A1, compound Example 1, has an IC50 of ≤100 nM[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: ≤100 nM (PD-1/PD-L1)[1] |
| In Vitro | The compounds modulate PD-1/PD-L1 protein/protein interaction and are useful in the treatment of various diseases including infectious diseases and cancer. The compounds can be used as immunomodulators[1]. |
| References |
[1]. Kaijiong Xiao, et al. Heterocyclic compounds as immunomodulators. WO2017222976A1. |
| Molecular Formula | C22H18N4O3S.xC2HF3O2 |
|---|